Two Sigma Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Two Sigma Securities’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,577	Closed	-$223K	–	2927
2018 Q1	$223K	Sell	3,577 -15,834	-82%	-$1.04M	﹤0.01%	2218
2017 Q4	$1.25M	Sell	19,411 -207,510	-91%	-$13.3M	0.03%	366
2017 Q3	$14.8M	Buy	+226,921	New	+$14.3M	1.35%	9
2017 Q2	–	Sell	-5,043	Closed	-$296K	–	1102
2017 Q1	$296K	Buy	+5,043	New	+$295K	0.06%	376
2016 Q4	–	Sell	-12,022	Closed	-$741K	–	884
2016 Q3	$741K	Buy	+12,022	New	+$787K	0.25%	92

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Securities's PJP Position: Q2 2018 in Review

Two Sigma Securities sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 3,577 shares — an estimated $223K sold.

Two Sigma Securities first reported a position in PJP in Q3 2016 and held it in 5 quarters. The position peaked at $14.8M in Q3 2017. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Two Sigma Securities reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Two Sigma Securities sold 3,577 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $223K.
Two Sigma Securities first reported a position in Invesco Pharmaceuticals ETF in Q3 2016 and held it in 5 quarters.
Two Sigma Securities's Invesco Pharmaceuticals ETF position peaked at $14.8M in Q3 2017.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Two Sigma Securities's 13F filing for Q2 2018, filed 14 Aug 2018.